TY  - GEN
AU  - Chowdary,P
AU  - Lethagen,S
AU  - Friedrich,U
AU  - Brand,B
AU  - Hay,C
AU  - Abdul Karim,F
AU  - Klamroth,R
AU  - Knoebl,P
AU  - Laffan,M
AU  - Mahlangu,J
AU  - Miesbach,W
AU  - Dalsgaard Nielsen,J
AU  - Martín-Salces,M
AU  - Angchaisuksiri,P
TI  - Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
SN  - 1538-7836
PY  - 2016///0211
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Area Under Curve
KW  - Double-Blind Method
KW  - Healthy Volunteers
KW  - Hemophilia A
KW  - drug therapy
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Placebos
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jth.12864
ER  -